Skip to search formSkip to main contentSkip to account menu

imidazobenzodiazepine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1995
Review
1995
Pharmacology of flumazenil
Flumazenil, an imidazobenzodiazpine, is the first benzodiazepine antagonist available for clinical use. It is a specific… 
1993
1993
Natural mutation of GABAA receptor alpha 6 subunit alters benzodiazepine affinity but not allosteric GABA effects.
Review
1991
Review
1991
Midazolam use in the emergency department.
Review
1988
Review
1988
Molecular interactions of ethanol with GABAergic system and potential of RO15–4513 as an ethanol antagonist
Highly Cited
1986
Highly Cited
1986
A selective imidazobenzodiazepine antagonist of ethanol in the rat.
Ethanol, at pharmacologically relevant concentrations of 20 to 100 mM, stimulates gamma-aminobutyric (GABA) receptor-mediated… 
Review
1985
Review
1985
Midazolam: Pharmacology and Uses
Midazolam is an imidazobenzodiazepine with unique properties when compared with other benzodiazepines. It is water soluble in its… 
1985
1985
Specific changes in local cerebral glucose utilization in the rat brain induced by acute and chronic diazepam
Review
1984
Review
1984
Midazolam. A review of its pharmacological properties and therapeutic use.
Midazolam is a short-acting water-soluble benzodiazepine (at pH less than 4), a member of a new class of imidazobenzodiazepine… 
Review
1983
Review
1983
On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and beta-carboline derivatives
Highly Cited
1983
Highly Cited
1983
Midazolam, a new more potent benzodiazepine, compared with diazepam: a randomized, double-blind study of preendoscopic sedatives.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License